Neurocrine Biosciences continues to underperform Vertex Pharmaceuticals by 45.8% year to date

  • Arthur G. Lyons

Press/Media

Period2 May 2025

Media coverage

1

Media coverage

  • TitleNeurocrine Biosciences continues to underperform Vertex Pharmaceuticals by 45.8% year to date
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date2/05/25
    PersonsArthur G. Lyons
View all 1
View less